Inhibition of the m(6)A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignant leukemia with extremely limited treatment for relapsed patients. N6‐methyladenosine (m(6)A) reader insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) participates in the initiation and growth of cancers by communicatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Panpan, Chen, Dawei, Wang, Xia, Li, Yanxia, Li, Zhenyu, Li, Boya, Zhang, Yupeng, Li, Wei, Zhang, Jingru, Ye, Jingjing, Zhao, Baobing, Li, Jingxin, Ji, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417996/
https://www.ncbi.nlm.nih.gov/pubmed/35915142
http://dx.doi.org/10.1038/s41375-022-01651-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417996/
https://www.ncbi.nlm.nih.gov/pubmed/35915142
http://dx.doi.org/10.1038/s41375-022-01651-9

Ejemplares similares